Masaya Enomoto1, Keigo Shigeta1, Takahiro Ota2, Tatsuo Amano3, Masayuki Ueda4, Yuji Matsumaru5, Yoshiaki Shiokawa6, Teruyuki Hirano3. 1. Department of Neurosurgery, National Hospital Organization Disaster Medical Center, Tokyo, Japan. 2. Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan. 3. Department of Stroke and Cerebrovascular Medicine, Kyorin University, Tokyo, Japan. 4. Department of Neurology and Stroke Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan. 5. Division of Stroke Prevention and Treatment, Department of Neurosurgery, University of Tsukuba, Tsukuba, Ibaraki, Japan. 6. Department of Neurosurgery, Kyorin University, Tokyo, Japan.
Abstract
BACKGROUND: Limited data are available regarding the predictors, clinical relevance, and bleeding rate by surgical devices of intracranial hemorrhage after endovascular thrombectomy. This is partially explained by the difference in the classification and definition of hemorrhage among studies. The purpose of this study was to identify the predictors of hemorrhagic transformation and isolated subarachnoid hemorrhage after endovascular thrombectomy. METHODS: This was a retrospective, multicenter observational cohort study of consecutive patients who underwent endovascular thrombectomy between January 2015 and December 2018. Univariate and logistic regression analyses were performed to determine the predictors, the impact on clinical outcomes, and the bleeding rate by surgical devices of hemorrhagic transformation and isolated subarachnoid hemorrhage. RESULTS: Among 610 eligible patients, hemorrhagic transformations occurred in 93 (15.2%). Fourteen patients (2.3%) were classified as having symptomatic intracranial hemorrhage. Isolated subarachnoid hemorrhage was found in 60 (9.8%) patients. In the logistic regression analyses, diabetes mellitus (odds ratio: 1.92; 95% confidence interval: 1.06-3.49) was associated with hemorrhagic transformation, and the number of device passes (odds ratio: 1.33; 95% confidence interval: 1.11-1.59) was associated with isolated subarachnoid hemorrhage. Both hemorrhagic transformation and isolated subarachnoid hemorrhage were associated with poor 90-day functional outcomes. There was a significant correlation between treatment with stent retrievers and isolated subarachnoid hemorrhage. CONCLUSIONS: Patients with diabetes mellitus were vulnerable to hemorrhagic transformation, whereas those who underwent several attempts of thrombectomy were susceptible to isolated subarachnoid hemorrhage. Both hemorrhage types worsened the functional outcome. Treatment with the stent retriever was significantly associated with postprocedural isolated subarachnoid hemorrhage.
BACKGROUND: Limited data are available regarding the predictors, clinical relevance, and bleeding rate by surgical devices of intracranial hemorrhage after endovascular thrombectomy. This is partially explained by the difference in the classification and definition of hemorrhage among studies. The purpose of this study was to identify the predictors of hemorrhagic transformation and isolated subarachnoid hemorrhage after endovascular thrombectomy. METHODS: This was a retrospective, multicenter observational cohort study of consecutive patients who underwent endovascular thrombectomy between January 2015 and December 2018. Univariate and logistic regression analyses were performed to determine the predictors, the impact on clinical outcomes, and the bleeding rate by surgical devices of hemorrhagic transformation and isolated subarachnoid hemorrhage. RESULTS: Among 610 eligible patients, hemorrhagic transformations occurred in 93 (15.2%). Fourteen patients (2.3%) were classified as having symptomatic intracranial hemorrhage. Isolated subarachnoid hemorrhage was found in 60 (9.8%) patients. In the logistic regression analyses, diabetes mellitus (odds ratio: 1.92; 95% confidence interval: 1.06-3.49) was associated with hemorrhagic transformation, and the number of device passes (odds ratio: 1.33; 95% confidence interval: 1.11-1.59) was associated with isolated subarachnoid hemorrhage. Both hemorrhagic transformation and isolated subarachnoid hemorrhage were associated with poor 90-day functional outcomes. There was a significant correlation between treatment with stent retrievers and isolated subarachnoid hemorrhage. CONCLUSIONS:Patients with diabetes mellitus were vulnerable to hemorrhagic transformation, whereas those who underwent several attempts of thrombectomy were susceptible to isolated subarachnoid hemorrhage. Both hemorrhage types worsened the functional outcome. Treatment with the stent retriever was significantly associated with postprocedural isolated subarachnoid hemorrhage.
Authors: Michael Mazya; José A Egido; Gary A Ford; Kennedy R Lees; Robert Mikulik; Danilo Toni; Nils Wahlgren; Niaz Ahmed Journal: Stroke Date: 2012-03-22 Impact factor: 7.914
Authors: Bijoy K Menon; Jeffrey L Saver; Shyam Prabhakaran; Mathew Reeves; Li Liang; Daiwai M Olson; Eric D Peterson; Adrian F Hernandez; Gregg C Fonarow; Lee H Schwamm; Eric E Smith Journal: Stroke Date: 2012-07-17 Impact factor: 7.914
Authors: M Fiorelli; S Bastianello; R von Kummer; G J del Zoppo; V Larrue; E Lesaffre; A P Ringleb; S Lorenzano; C Manelfe; L Bozzao Journal: Stroke Date: 1999-11 Impact factor: 7.914
Authors: Ulf Neuberger; Philipp Kickingereder; Silvia Schönenberger; Simon Schieber; Peter A Ringleb; Martin Bendszus; Johannes Pfaff; Markus A Möhlenbruch Journal: Neuroradiology Date: 2019-02-18 Impact factor: 2.804
Authors: Abhi Pandhi; Georgios Tsivgoulis; Rashi Krishnan; Muhammad F Ishfaq; Savdeep Singh; Daniel Hoit; Adam S Arthur; Christopher Nickele; Andrei Alexandrov; Lucas Elijovich; Nitin Goyal Journal: J Neurointerv Surg Date: 2017-12-19 Impact factor: 5.836
Authors: Daniel Strbian; Stefan Engelter; Patrik Michel; Atte Meretoja; Lucka Sekoranja; Frank J Ahlhelm; Satu Mustanoja; Igor Kuzmanovic; Tiina Sairanen; Nina Forss; Maria Cordier; Philippe Lyrer; Markku Kaste; Turgut Tatlisumak Journal: Ann Neurol Date: 2012-05 Impact factor: 10.422
Authors: Perry P Ng; Theodore C Larson; Christopher W Nichols; Mark M Murray; Karen L Salzman; Richard H Smith Journal: J Neurointerv Surg Date: 2018-06-21 Impact factor: 5.836